(Q46821304)

English

Risperidone, haloperidol, and placebo in the treatment of aggressive challenging behaviour in patients with intellectual disability: a randomised controlled trial

scientific article published in January 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18177776

Risperidone, haloperidol, and placebo in the treatment of aggressive challenging behaviour in patients with intellectual disability: a randomised controlled trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18177776

0 references

0 references

1 reference

based on heuristic

inferred from title

intellectual disability

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

disability affecting intellectual abilities

1 reference

based on heuristic

inferred from title

7

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18177776

13

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18177776

Shamshad Karatela

object named as

Shamshad Karatela

19

0 references

Mike J Crawford

object named as

Mike Crawford

21

1 reference

ORCID Public Data File 2021

author name string

Peter Tyrer

1

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18177776

Patricia C Oliver-Africano

2

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18177776

Zed Ahmed

3

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18177776

Nick Bouras

4

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18177776

Sherva Cooray

5

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18177776

Shoumitro Deb

6

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18177776

Monica Hare

8

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18177776

Michael Meade

9

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18177776

Ben Reece

10

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18177776

Kofi Kramo

11

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18177776

Sabyasachi Bhaumik

12

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18177776

Adrienne Regan

14

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18177776

David Thomas

15

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18177776

Bharti Rao

16

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18177776

Bernard North

17

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18177776

Joseph Eliahoo

18

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18177776

Anju Soni

20

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18177776

language of work or name

0 references

publication date

1 January 2008

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18177776

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18177776

371

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18177776

9606

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18177776

57-63

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18177776

Prevalence and cluster typology of maladaptive behaviors in a geographically defined population of adults with learning disabilities.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960072-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Mental ill-health in adults with intellectual disabilities: prevalence and associated factors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960072-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A study of the prescribing for people with learning disabilities living in the community and in National Health Service care.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960072-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Frequency of and determinants for psychotropic drug use in an institution for the mentally retarded.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960072-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The prevalence of psychiatric morbidity in mentally retarded adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960072-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects of help patterns on the mental health of spouse caregivers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960072-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960072-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Reliability and validity of the Mini PAS-ADD for assessing psychiatric disorders in adults with intellectual disability.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960072-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Risperidone as add-on therapy in behavioural disturbances in mental retardation: a double-blind placebo-controlled cross-over study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960072-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Short- and long-term efficacy and safety of risperidone in adults with disruptive behavior disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960072-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Receipt of psychotropic medication by people with intellectual disability in residential settings.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960072-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Are antipsychotic drugs the right treatment for challenging behaviour in learning disability?: The place of a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960072-0

7 January 2021

based on heuristic

inferred from DOI database lookup

An inpatient treatment model for adults with mild intellectual disability and challenging behaviour.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960072-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Risperidone in children with autism and serious behavioral problems

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960072-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Zuclopenthixol in adults with intellectual disabilities and aggressive behaviours: discontinuation study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960072-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Rapid tranquillisation of violent or agitated patients in a psychiatric emergency setting. Pragmatic randomised trial of intramuscular lorazepam v. haloperidol plus promethazine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960072-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(08)60072-0

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18177776

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18177776

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46821304&oldid=2133457580"